4
Changes in Ownership
Werewolf Therapeutics, Inc. Filed Acc 0001134657-25-000014
Director sold 128,185 shares at an average $0.92 ($117,623)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| EVNIN LUKE Director | 2025-12-02 | Sale 10b5-1 | −38,043 | $0.89 | $33,858 | 3,158,420 | I |
| EVNIN LUKE Director | 2025-12-03 | Sale 10b5-1 | −36,726 | $0.87 | $31,952 | 3,121,694 | I |
| EVNIN LUKE Director | 2025-12-04 | Sale 10b5-1 | −53,416 | $0.97 | $51,814 | 3,068,278 | I |
| Open-market sales · 128,185 sh · avg $0.92 · $117,623 | |||||||
Loading xslF345X05/form4-12042025_111226.xml…